Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 Diabetes Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02671968
What this trial is testing

Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)

Who this might be right for
Diabetes
Science Consulting in Diabetes 141
Not applicableUnknownNCT04835350
What this trial is testing

Feasibility and Safety Study of the Automated Insulin Delivery Closed Loop System Pancreas4ALL

Who this might be right for
Type 1 Diabetes
Lenka Petruzelkova 16
Post-approval studies (Phase 4)Study completedNCT04030091
What this trial is testing

Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Sciema UG 24
Not applicableUnknownNCT06460558
What this trial is testing

T1D Closed-loop and Physical Activity

Who this might be right for
Diabetes type1
Centre Hospitalier Universitaire de Nice 65
Very early researchEnrolling By InvitationNCT07503028
What this trial is testing

An Exploratory Clinical Study Evaluating Allogeneic iPSC-derived Pancreatic Islet Cells (CRG-002) for the Treatment of Diabetic Patients With Hypoglycemia Unawareness or Severe Hypoglycemic Events

Who this might be right for
T1DM - Type 1 Diabetes MellitusPancreatogenic Diabetes Mellitus
Celregen Therapeutics 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07616206
What this trial is testing

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems

Who this might be right for
Type 1 Diabetes (T1D)
vTv Therapeutics 40
Not applicableStudy completedNCT05980026
What this trial is testing

Omega-3 Fatty Acids Supplementation Improves Early-stage Diabetic Nephropathy and Subclinical Atherosclerosis in Pediatric Patients With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Ain Shams University 70
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Not applicableUnknownNCT02023489
What this trial is testing

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Who this might be right for
Type 2 Diabetes MellitusPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Familiar Hypocalcuric Hypercalcemia+2 more
Medical University of Vienna 90
Early research (Phase 1)Study completedNCT01919385
What this trial is testing

Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia

Who this might be right for
Type 1 Diabetes
Animas Corporation 12
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Post-approval studies (Phase 4)Study completedNCT01331317
What this trial is testing

Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy

Who this might be right for
Cardiovascular DiseaseDiabetic Nephropathy
Peter Rossing 48
Not applicableStudy completedNCT05442398
What this trial is testing

Celiac Disease and Diabetes Mellitus

Who this might be right for
Celiac Disease in Children
Mohamed Salah Ahmed Ali 41
Early research (Phase 1)Study completedNCT01394055
What this trial is testing

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

Who this might be right for
Diabetes Mellitus Type 1 and 2Diabetes Mellitus ComplicationsGastroparesis+1 more
Motus Therapeutics, Inc. 20
Not applicableStudy completedNCT02308293
What this trial is testing

The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia

Who this might be right for
Type 1 Diabetes MellitusHypoglycemia Unawareness
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT01969747
What this trial is testing

Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days

Who this might be right for
Diabetes Mellitus, Type 1
Boehringer Ingelheim 75
Not applicableStudy completedNCT06264271
What this trial is testing

The Effect of Nutrition Education on Glycemic Control in Patients With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Charles University, Czech Republic 329
Early research (Phase 1)Study completedNCT01188863
What this trial is testing

Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 15
Not applicableUnknownNCT04474535
What this trial is testing

C-peptide Correlation With Microvascular Complications in T1DM

Who this might be right for
Type 1 DiabetesC-peptideDiabetes Complications
National and Kapodistrian University of Athens 200
Testing effectiveness (Phase 2)Study completedNCT03335371
What this trial is testing

Evaluation of TTP399 in Patients With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
vTv Therapeutics 115
Next Page